Financials

News Discussions Technicals Forecast Seasonals

SOM fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

SomnoMed Ltd. engages in the production and sale of devices for the oral treatment of sleep related disorders. Its products include SomnoDent, SomMorning Repositioner, SomnoBrux, SomTabs, and Sunrise Sleep Test. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded in 2004 and is headquartered in Sydney, Australia.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

SOM has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company